It’s no secret that we’re living amidst a mental health crisis. More than 100 million people around the world have treatment-resistant depression—and we’re in desperate need of novel treatments for a host of conditions from post-traumatic stress to mood disorders. Whether you’re a person who is suffering, have a loved one who is suffering, or you’re interested in working in the field of mental health and psychedelics, this webinar is for you. We’ll discuss with Dr. Alan Davis the shortcomings of our current mental health system—and the novel treatments that are being investigated, from psilocybin therapy to harm reduction and beyond. At DoubleBlind, we often talk about the promise of psychedelics for mental health—in this webinar, we’ll offer some greater context into the systemic issues that need to be resolved to offer relief to the many who need it.
If you cannot afford the suggested sliding scale, email hello@doubleblindmag.com to be registered.
About Dr. Alan Davis
Dr. Davis’s clinical and research training was motivated by answering the following question: Why do evidenced-based psychotherapies fail and how can we improve them? As part of his training, he worked primarily with adults in a variety of community and clinical research settings, including academic medical centers, university clinics, community programs, and long-term acute care hospitals, delivering a variety of evidenced-based and experimental psychotherapies to individuals diagnosed with substance use, trauma-related, mood, and anxiety disorders. Grounded in a humanistic and process-oriented approach, such interventions included motivational interviewing, cognitive behavioral therapy, harm reduction, acceptance and commitment therapy, cognitive processing and prolonged exposure therapies, and psilocybin-assisted psychotherapy. These clinical approaches were complemented by extensive research training, wherein he had broad exposure to different research methodologies and advanced statistical techniques. Consistent with his clinical interests, his research interests and expertise focus on contributing to the knowledge of and ability to help those suffering with substance use and mental health problems. Understanding how to improve clinical outcomes through examining novel treatments and developing ways to conceptualize substance use and mental health problems through a strengths-based approach have been the guiding framework of his professional career.